We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Biohaven
BHVN
$2.16B
| $23.7K | ﹤0.01% |
2,798
+882
| +46% | +$9.65K |
|
|
BDN
1902
Brandywine Realty Trust
BDN
$551M
| $23.6K | ﹤0.01% |
8,698
+3,678
| +73% | +$11K |
|
1903
NextDecade
NEXT
$1.85B
| $23.4K | ﹤0.01% |
3,056
+1,000
| +49% | +$5.69K |
|
1904
Avanos Medical
AVNS
$1.17B
| $23.3K | ﹤0.01% |
1,665
+490
| +42% | +$6.6K |
|
|
DAWN
1905
DELISTED
Day One Biopharmaceuticals
DAWN
| $23.3K | ﹤0.01% |
1,088
+324
| +42% | +$4.57K |
|
1906
GlobalFoundries
GFS
$29.4B
| $23.2K | ﹤0.01% |
522
-65,099
| -99% | -$2.87M |
|
1907
Greif Class B
GEF.B
$3.65B
| $23.2K | ﹤0.01% |
265
+94
| +55% | +$7.93K |
|
1908
Four Corners Property Trust
FCPT
$2.86B
| $23.2K | ﹤0.01% |
980
+82
| +9% | +$2.03K |
|
1909
Leggett & Platt
LEG
$1.52B
| $23.1K | ﹤0.01% |
2,342
+633
| +37% | +$7.23K |
|
1910
QuidelOrtho
QDEL
$1.09B
| $23.1K | ﹤0.01% |
1,407
+355
| +34% | +$8.72K |
|
1911
Gentherm
THRM
$1.31B
| $23.1K | ﹤0.01% |
832
+392
| +89% | +$12.8K |
|
1912
Mobileye
MBLY
$2.03B
| $23.1K | ﹤0.01% |
3,360
+969
| +41% | +$8.78K |
|
1913
Ecovyst
ECVT
$1.36B
| $23K | ﹤0.01% |
1,792
+374
| +26% | +$4.22K |
|
1914
American Airlines Group
AAL
$9.58B
| $22.8K | ﹤0.01% |
2,119
+527
| +33% | +$6.98K |
|
1915
AvePoint
AVPT
$2.6B
| $22.7K | ﹤0.01% |
2,390
+591
| +33% | +$6.66K |
|
1916
Horace Mann Educators
HMN
$2.1B
| $22.7K | ﹤0.01% |
532
+62
| +13% | +$2.68K |
|
1917
Mineralys Therapeutics
MLYS
$2.35B
| $22.7K | ﹤0.01% |
+837
| New | +$24.5K |
|
|
LX
1918
LexinFintech Holdings
LX
$244M
| $22.6K | ﹤0.01% |
10,387
| – | – |
|
1919
Park National Corp
PRK
$3.41B
| $22.6K | ﹤0.01% |
138
+36
| +35% | +$5.89K |
|
1920
PACS Group
PACS
$7.42B
| $22.5K | ﹤0.01% |
+699
| New | +$25.7K |
|
|
WSR
1921
DELISTED
Whitestone REIT
WSR
| $22.4K | ﹤0.01% |
1,388
+535
| +63% | +$8.06K |
|
1922
Enviri
NVRI
$621M
| $22.4K | ﹤0.01% |
1,141
+250
| +28% | +$4.64K |
|
1923
WaFd
WAFD
$2.72B
| $22.3K | ﹤0.01% |
711
+52
| +8% | +$1.67K |
|
1924
Quantum Computing Inc
QUBT
$1.68B
| $22.3K | ﹤0.01% |
3,250
+624
| +24% | +$5.7K |
|
1925
Federal Agricultural Mortgage
AGM
$2.27B
| $22.3K | ﹤0.01% |
150
+30
| +25% | +$4.91K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.